The "cocktail" of human origin rifampicin-resistant bifidobacteria (RRBs) and RRBs from commercial products was administrated to 9 volunteers aged from 22 to 46 years and the survival ability in gastrointestinal tract of these strains was determined. Bifidobacteria represented 0-8 % of total anaerobes detected in gastrointestinal tract of volunteers before the administration of probiotic strains. After the administration of probiotics, bifidobacterial counts increased to 16 % of total bacterial counts. RRBs formed 9-44 % of total counts of bifidobacteria. Then, the counts of RRBs decreased at day 7 after administration, and they were not detected after 14 d. In our study, suitable probiotic bifidobacterial strains for human should be chosen on the basic of in vitro test but the results showed that no strain was able to colonize human tract permanently.

Department of Microbiology Nutrition and Dietetics Faculty of Agrobiology Food and Natural Resources Czech University of Life Sciences Prague 165 21 Prague 6 Czech Republic

Zobrazit více v PubMed

J Pediatr Gastroenterol Nutr. 1995 Aug;21(2):177-81 PubMed

J Appl Microbiol. 2001 Jan;90(1):43-52 PubMed

Appl Environ Microbiol. 1999 Oct;65(10):4506-12 PubMed

Folia Microbiol (Praha). 2008;53(3):214-6 PubMed

Am J Clin Nutr. 2001 Feb;73(2 Suppl):399S-405S PubMed

Gut. 1991 Apr;32(4):439-42 PubMed

Folia Microbiol (Praha). 2008;53(3):263-9 PubMed

Gastroenterology. 1992 Mar;102(3):875-8 PubMed

Int J Food Microbiol. 1999 Apr 1;48(1):51-7 PubMed

J Microbiol Methods. 2000 Dec 15;43(2):127-32 PubMed

Appl Environ Microbiol. 1996 Apr;62(4):1242-7 PubMed

Immunol Cell Biol. 2000 Feb;78(1):80-8 PubMed

J Nutr. 1997 Jan;127(1):89-94 PubMed

Food Microbiol. 2008 Feb;25(1):169-76 PubMed

Folia Microbiol (Praha). 2008;53(2):99-104 PubMed

Am J Clin Nutr. 1992 Jan;55(1):78-80 PubMed

Syst Appl Microbiol. 2000 Oct;23(3):391-9 PubMed

Microbiol Immunol. 1992;36(7):683-94 PubMed